Gallbladder Neoplasms: all 255 studies

Page 3 of 3. Open to participants first (61), then studies with results posted, then the rest; newest registration first within each.

• Study of Capecitabine and Oxaliplatin in Combination With Radiotherapy in Patients With Unresectable Gastro-Intestinal CancerCompletedNCT01016639Phase 1/2
• Gemcitabine Hydrochloride, Oxaliplatin, and Erlotinib Hydrochloride in Treating Patients With Advanced Biliary Tract Cancer, Pancreatic Cancer, Duodenal Cancer, or Ampullary CancerCompletedNCT00987766Phase 1
• Everolimus, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Unresectable Solid Tumors Refractory to Standard TherapyCompletedNCT00949949Phase 1
• Psychological and Emotional Impact in Patients Undergoing Treatment For Metastatic Cancer Either in a Clinical Trial or as Standard Off-Trial TherapyTerminatedNCT00896467
• Quality of Life in Patients Undergoing Radiation Therapy for Primary Lung Cancer, Head and Neck Cancer, or Gastrointestinal CancerCompletedNCT00836992
• Permission to Collect Blood Over Time for ResearchTerminatedNCT00767234
• Study of Gemcitabine and Carboplatin in the Treatment of Metastatic or Recurrent Cholangiocarcinoma/Gallbladder CancerCompletedNCT00660140Phase 2
• Gemcitabine With/Out Capecitabine in Locally Advanced, Unresectable, or Metastatic Biliary CancerTerminatedNCT00658593Phase 3
• Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal CancerCompletedNCT00654160Phase 1
• Anonymous Testing of Pathology Specimens for BRCA Mutations in Ashkenazi Jewish Individuals Who Have CancerWithdrawnNCT00588263
• Quality Of Life in Patients With Malignant Biliary ObstructionCompletedNCT00579865
• Gemcitabine and Radiation Therapy in Treating Patients With Locally Advanced Upper Gastrointestinal CancerCompletedNCT00544193Phase 1
• Biliary Stenting With or Without Photodynamic Therapy in Treating Patients With Locally Advanced, Recurrent, or Metastatic Cholangiocarcinoma or Other Biliary Tract Tumors That Cannot Be Removed by SurgeryCompletedNCT00513539Phase 3
• Visceral Lymphatic Mapping Using Isosulfan Blue in Patients With Cancer of the Pancreas, Colon, Stomach, Small Intestine, or GallbladderCompletedNCT00489515
• Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic CancerCompletedNCT00486356Phase 1
• Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer.CompletedNCT00423254Phase 1
• Storage of Bile From Routine Procedures to Study Risk FactorsTerminatedNCT00414843
• Endoscopic Versus Percutaneous Drainage For Hilar Block in Gall Bladder CancerCompletedNCT00409864Not applicable
• Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal CancerCompletedNCT00397384Phase 1
• Palliative Biliary Stenting on the Quality of Life of Patients With Unresectable Carcinoma Gallbladder With Hiliar Block.CompletedNCT00391183Phase 2/3
• Study to Test the Benefit and Safety of GM-CT-01 in Combination With 5-FU to Treat Bile Duct and Gall Bladder CancerWithdrawnNCT00386516Phase 2
• Capecitabine or Observation After Surgery in Treating Patients With Biliary Tract CancerCompletedNCT00363584Phase 3
• HAI Via Interventionally Implanted Port Catheter SystemsStatus unknownNCT00356161Phase 2
• Avastin and Tarceva for Upper Gastrointestinal CancersCompletedNCT00350753Phase 2
• Fluorouracil, Cisplatin, and Radiation Therapy or Gemcitabine and Oxaliplatin in Treating Patients With Nonmetastatic Biliary Tract Cancer That Cannot Be Removed By SurgeryCompletedNCT00304135Phase 2/3
• Biliary Metal Stent Study: Metal Stents for Management of Distal Malignant Biliary ObstructionCompletedNCT00280709Phase 4
• Oxaliplatin, Gemcitabine, Erlotinib, and Radiation Therapy in Treating Patients With Unresectable and/or Metastatic Pancreatic Cancer or Biliary Tract CancerCompletedNCT00266097Phase 1
• Gemcitabine With or Without Cisplatin in Treating Patients With Unresectable Locally Advanced or Metastatic Cholangiocarcinoma or Other Biliary Tract TumorsCompletedNCT00262769Phase 3
• Stent Placement With or Without Photodynamic Therapy Using Porfimer Sodium as Palliative Treatment in Treating Patients With Stage III or Stage IV Cholangiocarcinoma That Cannot Be Removed By SurgeryWithdrawnNCT00253617Phase 3
• S0514 Sorafenib in Treating Patients With Unresectable or Metastatic Gallbladder Cancer or CholangiocarcinomaCompletedNCT00238212Phase 2
• Capecitabine, Oxaliplatin, Bevacizumab and Radiation Therapy in Patients With Biliary Tract and Gallbladder CancerCompletedNCT00142480Phase 2
• Gemcitabine and Cisplatin for Gallbladder and Biliary Tract CancerCompletedNCT00123825Phase 2
• EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung CancerTerminatedNCT00087191Not applicable
• Gemcitabine and Capecitabine in Treating Patients With Advanced and/or Inoperable Cholangiocarcinoma or Carcinoma of the GallbladderCompletedNCT00084942Phase 2
• Adjuvant Palliative Capecitabine and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Biliary Tract CancerCompletedNCT00073905Phase 2
• Gemcitabine Plus Pemetrexed Disodium in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder CancerCompletedNCT00059865Phase 1/2
• Erlotinib in Treating Patients With Unresectable Liver, Bile Duct, or Gallbladder CancerCompletedNCT00033462Phase 2
• 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)CompletedNCT00031681Phase 1
• Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic CancerCompletedNCT00028496Phase 1
• Vaccine Therapy in Treating Patients With Advanced or Metastatic CancerCompletedNCT00027534Phase 1
• BMS-247550 in Treating Patients With Liver or Gallbladder CancerTerminatedNCT00023946Phase 2
• Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or LymphomasCompletedNCT00019513Phase 1
• Vaccine Therapy in Treating Patients With Cancer of the Gastrointestinal TractTerminatedNCT00012246Phase 2
• Combination Chemotherapy in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder CancerCompletedNCT00009893Phase 2
• Rebeccamycin Analogue in Treating Patients With Advanced Liver and/or Biliary CancerTerminatedNCT00005997Phase 2
• DX-8951f in Treating Patients With Biliary CancerCompletedNCT00005938Phase 2
• Biological Therapy in Treating Patients With Metastatic CancerCompletedNCT00004604Phase 1
• Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/NeuCompletedNCT00004074Phase 1
• Photodynamic Therapy in Treating Patients With Cancer of the Bile Duct, Gallbladder, or PancreasCompletedNCT00003923Phase 2
• Dolastatin 10 in Treating Patients With Metastatic Or Recurrent Liver, Bile Duct, or Gallbladder CancerCompletedNCT00003557Phase 2
• Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal CancerCompletedNCT00003427Phase 1
• Radiation Therapy in Treating Patients With Bile Duct, Gallbladder, or Pancreatic CancerCompletedNCT00003411Phase 1
• Liposomal Doxorubicin in Treating Patients With Liver or Bile Duct CancerStatus unknownNCT00003296Phase 2
• Irinotecan in Treating Patients With Advanced Gallbladder or Bile Duct CancerCompletedNCT00003276Phase 2
• Interleukin-12 in Treating Patients With Cancer in the AbdomenCompletedNCT00003046Phase 1

← Gallbladder Neoplasms overview